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ABSTRACT  A  130,000  Mr  protein  was  isolated  from  human  platelets  by  sequential  DEAE- 
Sephacel and Sepharose CI-4B chromatography. Low shear viscometric measurements showed 
that the enriched protein after DEAE-Sephacel chromatography inhibited actin polymerization. 
This effect was somewhat greater in the presence  of EGTA than in the presence  of calcium. 
Further purification  by Sepharose  CI-4B  chromatography  resulted  in a complete  loss of this 
inhibitory  effect.  Studies  with fluorescent  actin detected  no nucleation  or "+" end  capping 
activity in either the DEAE-Sephacel-  or Sepharose CI-4B-purified vinculin.  Antibodies  raised 
in mice against the  130,000-mol-wt  protein were shown to cross-react  with chicken  gizzard 
vinculin and a similar molecular weight protein was detected in W138 cells and, Madin-Darby 
canine  kidney  cells.  Lysis experiments  with the Madin-Darby  canine  kidney  cells  indicated 
that most of the vinculin  was soluble  in  Triton X-100,  although  some  was found  associated 
with the  insoluble  cytoskeletal  residue.  By immunofluorescence,  vinculin  in W138 cells was 
localized  to adhesion  plaques as described  by others.  Discrete  localization  in  platelets  was 
also detected and appeared to depend on their state of adhesion and spreading.  The results 
of these experiments  suggest that human  platelets  contain a protein  similar  to vinculin.  It is 
not clear if platelet vinculin is associated with structures analogous to adhesion plaques found 
in  other  cell  types.  The  data  indicate  that  the  previously  reported  effects  of  nonmuscle 
vinculins on actin polymerization  may be due to a contaminant or contaminants. 
The organization of the actin filament network that partici- 
pates in a number of cellular activities including cell division, 
ciliary movement, cytokinesis, endocytosis, membrane reor- 
ganization, and secretion appears to be modulated by proteins 
that  are  subject themselves to  higher  order  regulation  (for 
review see  references  1 and 2).  One such protein, vinculin, 
with an Mr of 130,000, has been isolated from smooth muscle 
and HeLa cells (3, 4). By use ofimmunofluorescence methods, 
vinculin has been localized to adhesion plaques at the termini 
ofactin stress fibers in cultured fibroblasts (3, 4) and in striated 
muscle (5),  and to the junctional regions of cardiac muscle 
cells by use of immunoelectron microscopy (6-8). The bio- 
chemical studies on the effects of vinculin on actin assembly 
have been controversial. Jockusch and Isenberg (9) reported 
that vinculin binds to actin filaments and forms tightly packed 
paracrystalline bundles of 4-20 filaments that may be several 
hundred microns in length. They also (9) reported results of 
physical studies consistent with bundling, namely, a reduction 
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in the viscosity of polymerized actin, but they demonstrated 
no influence on filament nucleation. 
Wilkins and Lin (10)  reported a calcium-independent re- 
duction in the viscosity of F-actin by smooth muscle vinculin. 
Their results suggested that vinculin was bound tightly to the 
"+" ends of actin filaments, would increase the critical con- 
centration of actin  required  for polymerization, and would 
inhibit  both  filament assembly nucleated  by spectrin-actin 
complexes and  filament-filament interactions.  Wilkins  and 
Lin (10)  detected little paracrystal formation and suggested 
that  bundling  might  be  due  to  a  low  affinity binding  of 
vinculin  to  actin.  Using  somewhat different  experimental 
protocols, Burridge and Feramisco (11) reported results sim- 
ilar to those of Wilkins and Lin (10) for both smooth muscle 
vinculin and HeLa cell vinculin. The results with nonmuscle 
vinculin were reported to be similar to those with  chicken 
gizzard vinculin except that calcium was necessary for activity. 
Two studies have shown that platelets contain a  130,000 
669 Mr vinculinlike protein. Langer et at. (12) used antibodies for 
vinculin,  prepared  against  the  chicken  gizzard  protein,  to 
show  the presence  of a  cross-reacting  molecule  in  human 
platelets.  Recently, Koteliansky et at. (13) purified a vinculin- 
like  protein from  platelets.  This  material  cross  reacts  with 
antibodies against chicken gizzard vinculin, has physical prop- 
erties  similar  to those reported  for other vinculins (3, 4,  9, 
10), and decreases  the viscosity of F-actin solutions. 
Recent biochemical work (14-17) shows that most of the 
preparations  of  vinculin  used  previously  contain  small 
amounts  of  other  contaminating  proteins.  The  report  by 
Evans  et  al.  (17)  demonstrates  little  direct  interaction  of 
phosphocellulose-purified vinculin with actin. These studies 
suggest  that other vinculin binding proteins,  like  those re- 
ported by Burridge (18,  19) and Otto (20), will be important 
in actin-vinculin linkages. 
In this study, we have isolated a  130,000 Mr protein from 
human platelets with the characteristics  ofvinculin. Low shear 
viscometric studies showed an apparent effect of this DEAE- 
purified material  on the viscosity of F-actin. This activity was 
lost upon further purification of the 130,000-mol-wt molecule 
by gel filtration. The results are similar to those reported  for 
muscle vinculin in recent preliminary communications (14- 
17)  and demonstrate  that a  nonmuscle  vinculin does  not 
interact directly with actin. We have also shown that antibod- 
ies against platelet vinculin cross-react  with chicken gizzard 
vinculin, will stain adhesion plaques in WI38 cells, and show 
patterns of localization in spreading human platelets. 
MATERIALS  AND  METHODS 
Actin Purification:  Actin was purified from rabbit skeletal muscle by 
the method of Spudich and Watt (21) then gel filtered on  Sephadex G-t50 
following the procedure of MacLean-Fletcher and Pollard (22).  We determined 
actin concentrations using an extinction coefficient at 290  nm of 0.65  for  I 
mg/ml. 
Platelet  Extract Preparation:  Platelet concentrates were used within 
5 d  after blood was drawn  from  donors.  Erythrocytes and white blood cells 
were removed by centrifugation at  1.600  rpm,  -600 g,  in a  Sorvall HG-4L 
rotor (Dupont  Instruments-Sorvall, Newton, CT)  for  15  min.  Platelets were 
pelleted at 4,200  rpm,  ~4,500 g, in the same rotor for 30 min. The platelet 
pellets were gently resuspended in 25-30 vol of 125 mM NaCI, 5 mM KCI, 0.1 
mM EDTA, 20 mM phosphate, pH 6.5, and 1 mg/ml of glucose, then collected 
by eentrifugation at 3.700 rpm for 20 min in the HG-4L rotor. We repeated 
this washing procedure three times. Washed platelets were resuspended in ice- 
cold  I mM ATP, 5 mM dithiothreitol, 20 mM EGTA, and 20 mM potassium 
phosphate, pH  7.0.  Typically, 2  ml of buffer were used per unit, -50 ml of 
platelet rich plasma. The resuspended platelets were then lysed by sonication 
with a sonifier (Branson Sonic Power Co., Danbury, CT). The total sonication 
time was -9  rain, consisting of 18 30-s bursts interspersed with 30-s rests to 
minimize heating. The crude platelet lysate was brought to a final concentration 
of 0.6 M  KCI by the addition of solid KCI then stirred for 2 h at 4"C.  A high 
salt supernatant was obtained by centrifugation at  100,000 g  for 60 min then 
dialyzed against 50 mM  KCI,  1 mM  EGTA,  10 mM imidazole-HCl, pH 6.8. 
This dialysis step produces a substantial polymerization and gelation of actin 
and actin-associated proteins that eventually contract into a dense precipitate 
that we refer to as a contractile gel. This material was removed by centrifugation 
at 5.000 g for  10 rain. The contractile gel consists of actin, myosin, and other 
actin-associated proteins, but little of the 130,000 Mr species. The gel-depleted 
exlract was clarified further  by centrifugation at  100,000  g  for  60  min.  A 
vinculin enriched fraction was obtained by ammonium sulfate fractionation of 
the  100,000 g  supernatant. The pellet from a  0-35% ammonium sulfate cut 
was resuspended in, and dialyzed overnight against, buffer B from Feramisco 
and Burridge (23), 20 mM NaCI, 0.1  mM EDTA,  15 mM 2-mercaptoethanol, 
20 mM Tris-acetate, pH  7.6, and clarified by centrifugation at  I00,000 g  for 
60 rain. We have used varying amounts of material but usually start with from 
50 1o  100 U  of outdated platelets. This typically yields 75 to  150 ml of high 
salt extract at a protein concentration of 7 to 10 mg/ml. We have not attempted 
to determine the yield of vinculin from the following procedure with much 
precision because we have relatively little control over the quality of the starting 
material  when  working with  large numbers  of platelets. However,  we can 
routinely recover 8-10 mg vinculin/100 U of the DEAE step and 6-8 mg from 
the gel filtration step. This is enough material for a number of experiments and 
can be combined with our procedures for isolation of gelsolin (24). 
Isolation  and  Purification  of  Human  Platelet  Vinculin: 
Approximately 50 mg of the 35% ammonium sulfate fraction was loaded onto 
a 2.5 x  25 cm DEAE-Sephacel column equilibrated with buffer B. Alternatively. 
200-250 mg of the contractile gel depleted extract was used after dialysis  against 
buffer B. The column was washed with three column volumes of the equili- 
brating buffer and eluted with a  20-400  mM  NaCI gradient,  1,000  ml total 
volume, approximately as described by Feramisco and Burridge (23).  The first 
elution peak, which contained a highly enriched 130,000-mol-wt protein, was 
pooled, concentrated by ammonium sulfate precipitation (35%), and dialyzed 
against buffer B. For further purification, ~5 mg of the 130,000-mol-wt protein 
fraction was applied to a 2.5 ×  100 cm Sepharose CL-4B column equilibrated 
and eluted with buffer B. The fractions containing the 130,000-mol-wt protein 
were  pooled  and  reconcentrated  by  ammonium  sulfate  precipitation  then 
resuspended in and dialyzed against buffer B. 
Preparation  of Antiserum Against  Human  Platelet Vincu- 
fin:  BALB/c mice were immunized initially with 20 ug Sepharose CL-4B 
purified platelet vinculin these boosted three times at monthly intervals with 
20 ug protein. We determined antibody titers 2 wk after each boost with an 
enzyme-linked immunoabsorption assay using horseradish peroxidase-conju- 
gated goat anti-mouse antibodies from Cappel Laboratories, Inc. (Downington, 
PA)  and  2,2'-azino-di-[3-ethyl-benathiazoline sulfonate (6)  from  Boehringer 
Mannbeim as the enzyme substrate. 
Vinculin Localization in Cells by Indirect  Immunofluores- 
cence:  Cells of the human line W138 grown on glass coverslips, were fixed 
in 3% formaldehyde-1% dimethylsulfoxide in PBS,  lysed in acetone at -20"C~ 
and processed for indirect immunofluorescence by using the mouse antivinculin 
serum as the first antibody and fluorescein isothiocyanate conjugated goat anti- 
mouse serum as the second. Human platelets were allowed to spread on glass 
coverslips for  20  rain,  then  processed  for  immunofluorescence  studies as 
described above. The fluoreseein isothiocyanate-labeled goat anti-mouse anti- 
bodies were purchased from Miles Laboratories, Inc. (Elkhart, IN). 
Cytoskeletal Localization of Vinculin:  Confluent Marbin-Darby 
Canine Kidney (MDCK) ~ cell monolayer cultures were washed in PBS,  then 
immediately lysed in a buffer containing 100 mM NaCI,  10 mM Tris, pH 7.4, 
with  0.5%  Triton  and  either 0.1  mM  EDTA  or  0.1  mM  CaCI2,  In  some 
instances we dissociated cells from the culture plates with 0. ] % trypsin before 
lysis. 
Low Shear Viscometry:  We did low shear viscometry using a falling- 
ball assay according to  MacLean-Fletcher and  Pollard (25).  Approximately 
0.25 mg/ml of gel-filtered actin in 25 mM KCL  1 mM MgCI2, 0.5 mM ATP, 
20 mM PIPES, pH  6.8,  with either 0.1  mM CaC12 or 0.275  mM  EGTA was 
mixed with increasing amounts of the  130,000  protein, immediately drawn 
into a  100-ul  capillary pipette, then allowed to polymerize for 3 h. A stainless- 
steel ball was pushed through the meniscus and timed over a  2-cm fall.  Fall 
times were converted to apparent viscosity in centipoise using glycerol stand- 
ards. 
Actin Assembly:  A fluorescent actin assembly assay (24) was used to 
test for nucleation activity associated with the  130,000-mol-wl protein during 
purification. We prepared  fluorescent nitrobenzooxadiazole (NBD)-actin  by 
the procedure of Detmers et al. (26). Rabbit skeletal muscle actin was deriva- 
tized at cysteine residue 374  with N-ethylmaleimide and then  reacted with 
NBD chloride. Fluorescence measurements were done with an Aminco SPF- 
500  spectrofluorometer (SLM  Instruments,  Inc.,  Urbana,  IL)  temperature 
regulated at  25"C.  The  excitation wave  length  was  475  nm;  the  emission 
wavelength was 530 rim. NBD-F-actin has approximately a 2-to-2.2 fold higher 
quantum yield than NBD-G-actin and the fluorescence changes associated with 
polymerization are a direct measure of the conversion of monomer to polymer 
(26).  The rate of fluorescence change during polymerization is a  function of 
the number of growing filament ends, the rate(s) of monomer addition to these 
ends, and the concentration of monomeric actin. To monitor aclin assembly, 
we mixed 1.1  ml of a solution of the  130,000-mol-wt protein in 1 mM CaCI2, 
10 mM Tris, pH 7.2, with 50 #1 of a  1.8-2.2 mg/ml solution of NBD-G-actin. 
This was followed immediately by 50 td ofa 2 M KCI, 40 mM MgCI2 solution 
to initiate assembly. The maximum slope of the reaction was used as a measure 
of NBD-actin polymerization. 
Miscellaneous:  We did immunoblots according to Towbin et al. (27) 
and ran SDS-polyacrylamide gels according to Laemmli (28).  Protein concen- 
~Abbreviations used  in  this  paper. MDCK,  Madin-Darby  canine 
kidney; NBD,  nitrobenzooxadiazole. 
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bovine serum albumin as a standard. 
R  ES U LTS 
Purification of Human Platelet Vinculin 
The  procedure described by Feramisco and  Burridge for 
chicken gizzard (23) was used to prepare a  130,000  Mr en- 
riched protein fraction from human platelets. A protein pro- 
file  from the  DEAE-Sephacel purification  step is  shown  in 
Fig.  1A  with  a  corresponding SDS gel of various fractions 
(Fig.  1  B). The first peak centered at fraction 40 is enriched in 
the  130,000-mol-wt protein. In this separation, fractions 35 
to 44 were pooled and precipitated with ammonium sulfate, 
then dialyzed against buffer B. This material was assayed for 
effects on actin assembly or fractionated further by Sepharose 
C1-4B chromatography. The protein profile for one Sepharose 
CI-4B gel filtration experiment is given in Fig. 2A. The bulk 
of the  protein  elutes as  a  sharp peak resolved from higher 
molecular  weight  contaminants  and  aggregated  material, 
which  elutes in  the  early fractions.  SDS gels  of the  pooled 
vinculin fractions are shown in the inset of Fig. 2 and in Fig. 
5, lane 5. 
Gel-filtered Vinculin  Does Not Affect the 
Viscosity of F-Actin 
The effects of the  130,000-mol-wt protein, at two stages of 
purification,  on  the  viscosity of F-actin  were compared by 
using a falling-ball viscometer. The results are shown in Fig. 
3.  The  filled  symbols give  the  results  for  DEAE-purified 
vinculin in the presence of 0.1  mM Ca+* (triangles) or 0.275 
mM  EGTA (circles).  The  vinculin  enriched  fraction  from 
DEAE Sephacel (filled symbols) chromatography reduced the 
viscosity of F-actin with an activity that was somewhat more 
effective at lower Ca  *+ concentrations. In EGTA this material 
reduced the low-shear viscosity of 0.25 mg/ml of F-actin by 
90% at a  concentration of ~20 ug/ml, with a half-maximal 
effect seen at -8 ~g/ml. The molar ratio of the major 130,000- 
mol-wt  protein  to  actin  at  this  latter  concentration  was 
~ 1:100. The concentration of possible active factors must be 
10- to  100-fold  lower. In the presence of calcium a  similar 
effect was seen; however, the  concentration  necessary for a 
half-maximal effect was approximately three times greater. 
Very different results were found  for the  vinculin  purified 
further on Sepharose. The open symbols in  Fig.  3 give the 
results for platelet vinculin purified by gel-filtration on Seph- 
arose  CL-4B  after  DEAE  chromatography.  There  was  no 
effect of this  material on  the  viscosity of F-actin  in  either 
calcium or EGTA at vinculin  concentrations as high as 60 
~g/ml.  The  viscosity  data  argue  against  bundling  and  or 
crosslinking of filaments by purified platelet vinculin. 
Platelet Vinculin  Does Not Affect Actin Assembly 
We used the NBD-actin assembly assay to look for effects 
FIGURE  1  Fractionation of platelet extracts on DEAE-Sephacel. (Top)  Protein profile. Approximately 250 mg of contractile gel- 
depleted extract, dialyzed against buffer B, was loaded onto a 2.5 x  25 cm column of DEAE-Sephacel and eluted with a 20 to 
400 mM NaCI gradient in buffer B.  7.5-ml fractions were collected and analyzed for protein by the method of Bradford (29). 
Every third fraction from the column was analyzed on 7.5% SDS-polyacrylamide gels. The results are shown (bottom).  Fractions 
35-44 contained a prominent 130,000-mol-wt protein which was pooled and concentrated by ammonium sulfate  precipitation 
as described in Materials and Methods. From the left, the open arrowheads in the lower panel indicate fractions 35, 50, 65, 80, 
95, 110, and 125, respectively. The solid arrowheads indicate molecular weight markers: phosphorylase b, 94,000;  bovine serum 
albumin, 68,000;  ovalbumin, 45,000,  and carbonic anhydrase,  30,000. 
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of partially purified vincu- 
lin  on  Sepharose  CI-4B. 
The  vinculin-containing 
fractions isolated by DEAD 
Sephacel were pooled and 
concentrated  by  use  of 
ammonium  sulfate,  then 
resuspended  in  and  di- 
alyzed against buffer B. 10 
mg of this partially purified 
material was loaded onto a 
column (2.5  x  100 crn)  of 
SepharoseCI-4Band 
eluted with  buffer B. 3-ml 
fractions were collected  and  analyzed for  protein  by  use  of the 
method of Bradford  (29).  The protein profile is shown  here. The 
purified vinculin  in fractions 72-82 was pooled and concentrated 
by ammonium sulfate precipitation, then  resuspended in  and  di- 
alyzed against buffer B. The inset shows a 7.5% SDS gel run with 5 
,~g of the pooled protein. 
the specificity of the polyclonal antibodies. The left panel of 
Fig. 5 shows a Coomassie Blue-stained SDS polyacrylamide 
gel of various platelet fractions obtained during the purifica- 
tion  of the  130,000-mol-wt  protein  (lanes  1-5).  The  right 
panel  of Fig.  5  shows companion gels,  with  corresponding 
lane numbers, immunoblotted with the mouse antiserum. In 
whole  platelets,  lane  1,  the  130,000-mol-wt  protein  is  the 
major component that reacts with the antiserum, but we do 
detect a  minor band at  ~150,000 Mr,  which may be meta- 
vinculin  (31,  32).  The  150,000-mol-wt  species  is  always 
weakly stained and is seen most deafly in this gel in lanes 2 
and 3 of the immunoblot. There are additional peptides, with 
molecular weights of 85,000-90,000 and one at 40,000, that 
appear to be degradation products since they vary from one 
batch of platelets to the next and increase at some of the early 
purification  steps.  Nearly all  of the  130,000-mol-wt species 
(arrow) was solubilized by high-salt extraction, as judged by 
the intensity of staining (compare lanes  1 and 2  in the  im- 
munoblot),  and  there  was  an  increase  in  the  degradation 
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FIGURE  3  DEAE-purified vinculin affects the viscosity of actin. The 
effect  of vinculin  on  actin viscosity was measured  by  use  of the 
falling-ball method of MacLean-Fletcher and Pollard (24).  Partially 
purified vinculin  isolated by DEAE-Sephacel chromatography was 
assayed in the presence of 0.275 mM EGTA (filled circles) or in 0.1 
mM calcium (filled triangles). Vinculin,  purified through the addi- 
tional Sepharose Cl-4B chromatography step, was assayed  under 
the  same  conditions  in  EGTA  (open  circles)  or  calcium  (open 
triangles).  The  data  are  expressed  as  the  percent  of  the  actin 
controls. 
of gel filtered vinculin on both the rate of assembly and the 
final fluorescence values, which are a sensitive measure of the 
critical concentration of actin assembly. The results,  shown 
in Fig. 4, indicate that DEAE-purified vinculin has no signif- 
icant effect on either the rate or the critical concentration of 
assembly  in  either  Ca  ++  (Fig.  4A)  or  EGTA  (Fig.  4B)  at 
vinculin/actin ratios of up to l-to-15. We have found similar 
results for gel-filtered vinculin and have been unable to cor- 
relate the reduced viscosity seen in Fig. 3 with an end capping 
activity.  In this assay, for example,  10 nM  platelet gelsolin, 
whose capping activity we have established (25, 30), reduced 
the  final  fluorescence  value  35  to  40%  and  increased  the 
overall assembly rate about threefold. 
Antibody Specificity 
We produced antibodies in mice by use of the gel-filtered 
130,000-mol-wt protein. Immunoblots were used to establish 
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FIGURE  4  Partially  purified  platelet vinculin  does not alter actin 
assembly. The  assembly of actin was  measured by  use  of  NBD- 
actin  at  a  final  concentration  of  2.5  ~M.  The  base  line  of  actin 
assembly  in  the  presence  of  vinculin  was  offset  in  a  and  b  to 
enhance clarity. (a) The effect of vinculin on actin assembly in the 
presence of 0.1  mM calcium.  KCI  and MgCI2  were added at the 
open arrows to  final concentrations of  100 and  2.5  raM,  respec- 
tively, to initiate assembly. (b) Effect  of vinculin on actin assembly 
in 1 mM EGTA.  KCI and MgCI2 were added at the arrow to initiate 
assembly, as indicated in a. The filled symbols are the control actin 
preparations; the open symbols are for a vinculin concentration of 
25  /~g/ml,  an  actin/vinculin  molar  ratio  of  about  15:1.  Identical 
results  were obtained with the protein purified through the addi- 
tional Sepharose CI-4B step. FIGURE  5  Immunoblot  anal- 
ysis using polyclonal antibod- 
ies against platelet vinculin. A 
mouse  antiserum  to  human 
platelet vinculin was tested at 
a  dilution  of  1:1,000  against 
the following fractions, identi- 
fied  by  lane  numbers  at  the 
top  of  the  Coomassie  Blue- 
stained  gel  (left)  and  the 
corresponding  immunoblot 
(right):  (I)  whole platelets im- 
mediately  before  sonication; 
(2)  high  salt  extract after  the 
100,000  g  centrifugation;  (3) 
extract after dialysis and cen- 
trifugation to remove the con- 
tractile gel; (4) contractile gel; 
(5)  vinculin  after  DEAE and 
Sepharose  chromatography 
(see  inset  in  Fig.  2  also);  (6) 
chicken  gizzard  vinculin 
(kindly provided by Dr. Joann 
Otto,  Purdue  University,  La- 
fayette,  IN);  and  (8)  whole 
Wl38  cells.  Lane  M  has  the 
same molecular weight mark- 
ers as those used in Fig. 1; the 
arrow  indicates the  130,000- 
mol-wt position. K, thousands. 
FIGURE 6  Vinculin  localiza- 
tion  in  platelets.  Variation  in 
the  immunofluorescent stain- 
ing patterns of platelets seen 
usingthe mouse serum against 
platelet  vinculin  that  was 
tested  in  Fig.  5.  The  inset 
shows a cell that has attached 
to the glass coverslip and has 
begun  to  spread.  The  arrow 
indicates a well-spread cell or 
several cells.  The  arrowhead 
indicates  a  well-spread  cell 
that  has  a  morphology  that 
suggests  movement  toward 
the left. Vinculin is present in 
the leading edges and in larger 
aggregates  in  the  central  cy- 
toplasm. (Figure)  x  3,000; (in- 
set), x  5,000. 
products. The gelation step removes a substantial amount of 
actin,  myosin, and  alpha-actinin  but  little of the  130,000- 
mol-wt (compare the fourth lane in  both panels). We have 
tried, unsuccessfully, to induce vinculin to associate with the 
contractile gel by varying the salt conditions during dialysis, 
by activating the platelets with ADP or Ca  +* ionophores, and 
by using freshly drawn platelets. Lanes 5 and 6 compare the 
130,O00-mol-wt platelet protein with chicken gizzard vinculin 
and show that the mouse antibody also cross-reacts with the 
chicken  protein.  Lane  7  demonstrates  cross-reaction  of a 
130,O00-mol-wt  species in  the  WI38 cells  used for indirect 
immunofluorescence  localization.  We  noted  one  potential 
artifact in  doing gel  electrophoresis and  immunoblots with 
concentrated  vinculin  solutions.  We  occasionally observed 
the presence of high molecular cross-reacting material. This 
happened with samples that gave single bands on other runs 
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cells. Wl38 cells were processed for indirect immu- 
nofluorescence by use of the mouse serum against 
platelet vinculin  tested  in  Fig.  5.  The three panels 
show cells at various stages of spreading or moving. 
The  cell  in  the  middle,  for  example, seems to  be 
moving to the  left.  All  three  panels show vinculin 
staining in discrete bright foci. Weaker staining along 
or under stress fibers is also apparent in some cells. 
x  1,700. 
and could be eliminated by our using 2 rather than  1% SDS 
in  the  gel  electrophoresis  sample  buffer and  extending  the 
heating time to 5 min. 
Localization of the  130,000 Mr Protein in 
Human Platelets 
We have made preliminary observations of vinculin local- 
ization in platelets. Fig. 6 shows the results of allowing plate- 
lets to attach and spread on a glass cover slip before processing 
for conventional indirect immunofluorescence. The staining 
pattern varies depending on the stage of platelet attachment 
and spreading. In ceils that have attached and spread but that 
still have a circular profile (inset), there is a somewhat grainy 
or clumpy distribution of fluorescence in the cytoplasm and 
a  clear demarcation  of the  cell  boundary.  In cells  that  we 
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think are in the process of spreading (arrow), the fluorescence 
localization  was  more  discrete  and  was  focused  primarily 
around the central core of the platelet.  In some well-spread 
cells the fluorescence appeared fibrous and radially arranged 
(upper left of Fig. 6). Finally, some platelets looked like they 
were moving and  had well-defined tails that were intensely 
stained (arrowhead). 
Localization of the  130,000 Mr Protein in the 
Adhesion Plaques of Wl38 Cells 
In order to provide further evidence that the  130,000-mol- 
vvt platelet  protein  was  vinculin  we used  the  antibodies  to 
localize the cross-reacting protein  detected  in the  immuno- 
blots.  This  has been done for several cell types.  WI38 cells processed for indirect immunofluorescence showed, in Fig. 7, 
staining of foci similar in appearance to the adhesion plaques 
previously identified by others with antibodies against smooth 
muscle vinculin (3, 4). In a spreading cell (Fig. 7, top) staining 
was observed on these foci around the entire periphery. In 
motile cells (middle) antibody staining was observed in foci 
at the leading and trailing edges and scattered on the under 
surface. In cells at other stages of spreading (bottom) staining 
of discrete foci was also readily apparent. Some much weaker 
staining of stress fibers and the cell body was evident in some 
preparations. Elimination of  the first or second step antibodies 
abolished staining completely. 
Retention of Vinculin in MDCK 
Cell Cytoskeletons 
Finally, we used the antibodies and immunoblots to study 
the distribution of the  130,000-mol-wt protein after cell lysis 
with Triton X-100. Confluent MDCK cell monolayer cultures 
were used to study the  distribution  of vinculin  in attached 
cells lysed in the presence of Ca  ++ (Fig.  8, lanes 5 and 6) or 
in the presence of EGTA (Figure 8, lanes 3 and 4). Alterna- 
tively, confluent MDCK cell monolayers were trypsinized to 
disrupt adhesion contacts with the substrate before lysis (Fig. 
8,  lanes  1  and  2).  The  results  show  that  the  bulk  of the 
vinculin was soluble in the lysis buffer but that some vinculin 
remained associated with the attached cytoskeleton and that 
the Ca+* levels made little change in the amount of material 
retained. Little if any vinculin was retained in the Triton X- 
100 residues from unattached cells. Geiger has reported sim- 
ilar results using anti-chicken gizzard vinculin and attached 
cells (33). 
DISCUSSION 
As part of an overall investigation to isolate and characterize 
human platelet proteins that modify actin assembly we have 
purified, as described in this report, a  130,000-mol-wt protein 
with the characteristics of vinculin, a protein previously iso- 
lated from chicken gizzards (23). The platelet protein has the 
same molecular weight and solubility properties as the chicken 
protein  and  can  be  purified  using  similar  protocols  (23). 
Antibodies against the  130,000-mol-wt platelet protein cross 
reacted with chicken gizzard vinculin, stained focal adhesion 
plaques in WI38 cells, and gave patchy fluorescence in human 
platelets. Our results extend, but are only in partial agreement 
with, the reports by Wilkins and Lin (10) and Jockusch and 
Isenberg (9)  on smooth muscle vinculin, by Feramisco and 
Burridge  (11,  23)  on  both  smooth  muscle  and  nonmuscle 
vinculins, and by Koteliansky et al. (13) on platelet vinculin. 
Like all  of these  authors  we observed that  DEAE-purified 
vinculin affects the  viscosity of F-actin  solutions.  We were 
unable,  however, to detect capping activity as described by 
Wilkins and Lin (10) and have no evidence that the reduced 
viscosity is due to shortened filaments. Gel filtration removes 
some  minor components and  eliminates the  effect of this 
material  on  F-actin  viscosity.  This  result  agrees  with  the 
observations of others (14-16) and the report by Evans et al. 
(17) that DEAE-purified chicken gizzard vinculin has a con- 
taminant that interacts with actin, and extends these obser- 
vations to a nonmuscle vinculin. We have not identified the 
contaminating protein(s) that affect actin viscosity, but note 
that a minor component of the DEAE-purified vinculin is a 
high  molecular weight peptide similar to that described re- 
cently by Otto et al. (20) and by Burridge and co-workers (18, 
19).  It  is  not  clear  if we  have  removed  a  co-factor that 
potentiates vinculin-actin interactions or removed a distinct 
actin-associated protein. 
The cross-reactivity of the  antibody against the  130,000- 
mol-wt protein with chicken gizzard vinculin and  130,000- 
mol-wt proteins from other cells plus the immunofluorescence 
localization in focal adhesions provide the strongest evidence 
that the platelet protein is vinculin. This is supported by the 
MDCK cell lysis experiments, which also indicate that disrup- 
tion of the adhesions by trypsinization releases vinculin from 
the cytoskeleton. We have not established whether the vin- 
culin  retained  in  the  Triton  X-100  residue  is  a  different 
isoform as  recently described by Geiger (33).  We  have at- 
FIGURE  8  Vinculin  is  partially  retained  in  the  cytoskeleton  of 
MDCK  cells.  Samples  of  Triton  X-100  soluble  and  insoluble  or 
cytoskeletal proteins from  MDCK  cell  monolayers were analyzed 
by use of the mouse antiserum against platelet vinculin to immu- 
noblot  SDS  gels.  Lanes  1  and  2  are  the  insoluble  and  soluble 
fractions,  respectively, from  a trypsin-dissociated  cell  suspension. 
Lanes 3 and 4 are the insoluble and soluble fractions from attached 
cells lysed in Triton X-100 with 0.1  mM  EDTA added, and lanes 5 
and  6  are the corresponding fractions  after  lysis with  Triton  with 
0.1  mM calcium added.  Essentially all of the vinculin  in the unat- 
tached control cells seems to be released by Triton lysis, whereas 
in the latter two extractions some vinculin is retained in the insol- 
uble residue. K, thousands. 
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that retain vinculin but have not been successful. Some vin- 
culin, assayed by immunoblots, is retained in Triton X-100 
residues  (34)  and  in  the  contractile  gels  (Fig.  5),  but  the 
amounts do not exceed 2-3% of the total vinculin. 
The staining of platelets with antivinculin does show some 
localization in spreading cells at the cell periphery and some 
indication of fibrous bundles. The evidence that platelets have 
well-developed adhesion plaques is,  however, poor, and we 
do not observe discrete bright foci like those found in cultured 
cells.  We  are  now  trying  to  correlate  the  distribution  of 
vinculin in platelets seen with immunofluorescence with close 
contacts visualized by interference-reflection microscopy. The 
initial results with freshly drawn platelets indicate that close 
contact regions are very dynamic and appear to be associated 
with vinculin. 
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